loadpatents
Patent applications and USPTO patent grants for Parry; Gordon.The latest application filed is for "methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients".
Patent | Date |
---|---|
Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients Grant 11,401,344 - Huang , et al. August 2, 2 | 2022-08-02 |
Methods of determining patient response by measurement of HER-3 Grant 10,775,382 - Bates , et al. Sept | 2020-09-15 |
Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients App 20190055319 - Huang; Weidong ;   et al. | 2019-02-21 |
Methods of Determining Patient Response by Measurement of HER-3 App 20180164319 - Bates; Michael ;   et al. | 2018-06-14 |
Methods of determining patient response by measurement of HER-3 and P95 Grant 9,766,242 - Bates , et al. September 19, 2 | 2017-09-19 |
Methods of Determining Patient Response by Measurement of HER-2 Expression App 20170082626 - Bates; Michael ;   et al. | 2017-03-23 |
Methods of Determining Patient Response by Measurement of HER-3 App 20160061839 - Bates; Michael ;   et al. | 2016-03-03 |
HER-3 antibodies and methods of use Grant 9,110,066 - Bates , et al. August 18, 2 | 2015-08-18 |
Methods of Determining Patient Response by Measurement of HER-2 Expression App 20140370523 - Bates; Michael ;   et al. | 2014-12-18 |
Methods of Determining Patient Response by Measurement of HER-3 App 20130071859 - Bates; Michael ;   et al. | 2013-03-21 |
Methods of determining patient response by measurement of Her-3 Grant 8,349,574 - Bates , et al. January 8, 2 | 2013-01-08 |
Isolated human antibodies that bind epitopes on RG1 Grant 7,893,217 - Harkins , et al. February 22, 2 | 2011-02-22 |
Methods for treating disease-states associated with RG1 using immunoconjugates Grant 7,887,804 - Harkins , et al. February 15, 2 | 2011-02-15 |
Methods of Determining Patient Response By Measurement of HER-2 Expression App 20100233732 - Bates; Michael ;   et al. | 2010-09-16 |
Methods Of Determining Patient Response By Measurement Of Her-3 App 20100210034 - BATES; MICHAEL ;   et al. | 2010-08-19 |
Rg1 Antibodies And Uses Thereof App 20100081795 - Harkins; Richard ;   et al. | 2010-04-01 |
DNA encoding a novel RG1 polypeptide App 20090292112 - Harkins; Richard ;   et al. | 2009-11-26 |
RG1 antibodies and uses thereof Grant 7,611,706 - Harkins , et al. November 3, 2 | 2009-11-03 |
RG1 antibodies and uses thereof Grant 7,608,263 - Harkins , et al. October 27, 2 | 2009-10-27 |
DNA encoding a novel RG1 polypeptide App 20090214422 - Harkins; Richard ;   et al. | 2009-08-27 |
RG1 antibodies and uses thereof App 20080226656 - Harkins; Richard ;   et al. | 2008-09-18 |
RG1 antibodies and uses thereof App 20080138899 - Harkins; Richard ;   et al. | 2008-06-12 |
RG1 antibodies and uses thereof Grant 7,335,748 - Harkins , et al. February 26, 2 | 2008-02-26 |
DNA encoding a novel RG1 polypeptide Grant 7,307,154 - Harkins , et al. December 11, 2 | 2007-12-11 |
Novel prostate tumor-specific promoter App 20060188990 - Kretschmer; PeterJ ;   et al. | 2006-08-24 |
RG1 antibodies and uses thereof App 20050019845 - Harkins, Richard ;   et al. | 2005-01-27 |
DNA encoding a novel RG1 polypeptide App 20040152139 - Harkins, Richard ;   et al. | 2004-08-05 |
Modified hepsin molecules having a substitute activation sequence and uses thereof App 20040132156 - Parry, Gordon ;   et al. | 2004-07-08 |
DNA encoding a novel RG1 polypeptide App 20040023307 - Harkins, Richard ;   et al. | 2004-02-05 |
DNA encoding a novel RG1 polypeptide Grant 6,682,902 - Harkins , et al. January 27, 2 | 2004-01-27 |
DNA encoding a novel PROST 03 polypeptide App 20020009455 - Lau, Ted ;   et al. | 2002-01-24 |
DNA encoding a novel RG1 polypeptide App 20020004047 - Harkins, Richard ;   et al. | 2002-01-10 |
SEC | 0001428162 | Parry Gordon |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.